Basics |
Alto Neuroscience Inc.
|
IPO Date: |
February 2, 2024 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$61.72M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.34 | 4.03%
|
Avg Daily Range (30 D): |
$0.08 | 3.44%
|
Avg Daily Range (90 D): |
$0.11 | 4.36%
|
Institutional Daily Volume |
Avg Daily Volume: |
.29M |
Avg Daily Volume (30 D): |
.22M |
Avg Daily Volume (90 D): |
.25M |
Trade Size |
Avg Trade Size (Sh.): |
106 |
Avg Trade Size (Sh.) (30 D): |
119 |
Avg Trade Size (Sh.) (90 D): |
129 |
Institutional Trades |
Total Inst.Trades: |
68 |
Avg Inst. Trade: |
$1.64M |
Avg Inst. Trade (30 D): |
$1.39M |
Avg Inst. Trade (90 D): |
$1.26M |
Avg Inst. Trade Volume: |
.17M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$3.39M |
Avg Closing Trade (30 D): |
$3.88M |
Avg Closing Trade (90 D): |
$2.32M |
Avg Closing Volume: |
348.46K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-2.34
|
$-.56
|
$-.56
|
Diluted EPS
|
$-2.34
|
$-.56
|
$-.56
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -63.18M
|
$ -15.17M
|
$ -15.2M
|
Operating Income / Loss
|
$ -69.9M
|
$ -15.68M
|
$ -17M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -44.64M
|
$ -7.48M
|
$ -13.47M
|
PE Ratio
|
|
|
|
|
|
|